Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 765-771

  Kook, Joong Ki ^a   Kim, Jin Hong ^a   Min, Byung Moo ^a,b  

^a Seoul National University   (South Korea)

^b School of Dentistry   (South Korea)

Author keywords

HPV 16 E6 E7; HPV transformed human oral keratinocytes; NFI; Viral promoter P97

Indexed keywords

VIRUS DNA;

ARTICLE; CELL IMMORTALIZATION; DELETION MUTANT; DNA SEQUENCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRUS CELL TRANSFORMATION; VIRUS GENOME; WART VIRUS;

EID: 13144297195     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.765     Document Type: Article

References (36)

1. Zur Hausen H: Intracellular surveillance of persisting viral infections. Lancet II: 489-491, 1986.
2. Kellokoski JK, Syrjanen SM, Chang F, Yliskoski M and Syrjanen KJ: Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital infections. J Oral Pathol Med 21: 459-464, 1992.
3. Woods KV, Shillitoe EJ, Spitz MR, Schantz SP and Adler-Storthz K: Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med 22: 101-108, 1993.
4. Cuthill S, Sibbet GJ and Campo MS: Characterization of a nuclear factor, papillomavirus enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Mol Carcinogen 8: 96-104, 1993.
5. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR and Schiller JT: HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8: 3905-3910, 1989.
6. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417-4421, 1989.
7. Von Knebel Doeberitz M, Oltersdorf T, Schwarz E and Gissmann L: Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 48: 3780-3786, 1988.
8. Bosch FX, Schwarz E, Boukamp P, Fusenig NE, Bartsch D and zur Hausen H: Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa x fibroblast hybrid cells. J Virol 64: 4743-4754, 1990.
9. Dyson N, Howley PM, Munger K and Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937, 1989.
10. Werness BA, Levine AJ and Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
11. Rohlfs M, Winkenbach S, Meyer S, Rupp T and Durst M: Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virol 183: 331-342, 1991.
12. Bernard HU and Apt D: Transcriptional control and cell type specificity of HPV gene expression. Arch Dcrmatol 130: 210-215, 1994.
13. Cripe TP, Haugen TH, Turk JP, Tabatabai F, Schmid PG, Durst M, Issmann L, Roman A and Turek LP: Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by keratinocyte-dependent enhancer, and by viral E2 transactivator and represser gene products: implications for cervical carcinogenesis. EMBO J 6: 3745-3753, 1987.
14. Gloss B, Bernard HU, Seedorf K and Klock G: The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 6: 3735-3743, 1987.
15. Chong T, Apt D, Gloss B, Isa M and Bernard HU: The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NFI, and AP-1 participate in epithelial cell-specific transcription. J Virol 65: 5933-5943, 1991.
16. Smotkin D and Wettstein FO: Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 83: 4680-4684, 1986.
17. Chan WK, Chong T, Bernard HU and Klock G: Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promoters through AP 1 binding sites. Nucleic Acids Res 18: 763-769, 1990.
18. Hoppe-Seyler F and Butz K: Cellular control of human papillomavirus oncogene transcription. Mol Carcinogen 10: 134-141, 1994.
19. Gloss B, Chong T and Bernard HU: Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of.6 of 23 DNase I-protected segments coincides with the location of the cell-typc-specific enhancer. J Virol 63: 1142-1152, 1989.
20. Sibbet GJ and Campo MS: Multiple interactions between cellular factors and the non-coding reeion of human papillomavirus type 16. J Gen Virol 71: 2699-2707, 1990.
21. Gloss B, Yeo-Gloss M, Meisterernst M, Rogge L, Winnacker EL and Bernard HU: Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res 17: 3519-3533, 1989.
22. Chong T, Chan WK and Bernard HU: Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res 18: 465-470, 1990.
23. 97 promoter is defined with HPV-associated cellular events in human epithelial cell lines. Virology 195:500-510,1993.
24. Park N-H, Min B-M, Li S-L, Huang MZ, Chcrrick HM and Doniger J: Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogencsis 12: 1627-1631, 1991.
25. Min B-M, Woo K-M, Back J-H, Lee G and Park N-H: Malignant transformation of HPV-immortalized human oral keratinocytes by chemical carcinogens. Int J Oncol 7: 249-256, 1995.
26. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
27. Seedorf K, Krammer G, Durst M, Suhai S and Rowekamp WG: Human papillomavirus type 16 DNA sequence. Virology 145: 181-185, 1985.
28. Chen Z, Storthz KA and Shillitoe EJ: Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res 57: 1614-1619, 1997.
29. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
30. Yasumoto S, Taniguchi A and Sohma K: Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region. J Virol 65: 2000-2009, 1991.
31. Apt D, Chong T, Liu Y and Bernard HU: Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol 67: 4455-4463, 1993.
32. Falvey E and Schibler U: How are the regulators regulated? FASEB J 5: 309-314, 1991.
33. Nurnberg W, Artuc M, Vorbruggen G, Kalkbrenner F, Moelling K, Czarnetzki BM and Schadendorf D: Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. Br J Cancer 71: 1018-1024, 1995.
34. Santoro C, Mermod N, Andrews PC and Tjian R: A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature 334: 218-224, 1988.
35. Kim MS, Shin K-H, Baek J-H, Cherrick HM and Park N-H: HPV-16, tobacco-specific N-nitrosamine, N-methyl-N'-nitro-N-nitrosoguanidine in oral carcinogenesis. Cancer Res 53: 4811-4816, 1993.
36. Shin KH, Tannyhill RJ, Liu X and Park N-H: Oncogenic transformation of HPV-immortalized human oral keratinocytes is associated with the genetic instability of cells. Oncogene 12: 1089-1096, 1996.